Summarized by Plex Health
Last Updated: 02 May 2022
development and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis. "development and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis.", by Wu J, Zuo Y, Hu Y, Wang J, Li J, Qiao B, Jiang D. f1-dddt-9-1359: SEM images of unloaded PLGA microspheres and RPMs.Notes: (A) RPMs0, (B) RPMs20, (C) RPMs50, (D) RPMs100. RPMs0 denotes unloaded PLGA microspheres, RPMs20, RPMs50, and RPMs100 denote rifapentine-loaded PLGA microspheres with 20, 50, and 100...

PRIFTIN is a rifamycin antimycobacterial medicine showed in patients 12 years old and older for the therapy of active lung tuberculosis brought on by Mycobacterium tuberculosis in combination with several anti-tuberculosis drugs to which the isolate is susceptible. The 150 mg tablets consist of, as non-active active ingredients: calcium stearate, disodium EDTA, FD&C Blue No. 2 aluminum lake, hydroxypropyl cellulose, hypromellose USP, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, propylene glycol, salt ascorbate, salt lauryl sulfate, sodium starch glycolate, artificial red iron oxide, and titanium dioxide. Rifapentine is a rifamycin acquired antimicrobial and has a similar account of microbiological activity to rifampicin. The molecular weight is 877. 04. The molecular formula is C47H64N4O12. The chemical name for rifapentine is rifamycin, 3- [imino] methyl] - or 3- [N-formimidoyl] rifamycin or 5,6917,19,21-hexahydroxy-23-methoxy-2,412,16,18,20,22- heptamethyl-8 [N-formimidoyl] -2,7- naphtho [2,1-b] furan-1,11- dione 21-acetate. It has the adhering to structure.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
135403821C47H64N4O12877.0CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)CC[[email protected]]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[[email protected]](O4)(O/C=C/[[email protected]@H]([[email protected]]([[email protected]]([[email protected]@H]([[email protected]@H]([[email protected]@H]([[email protected]]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/CInChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1WDZCUPBHRAEYDL-GZAUEHORSA-N[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate6.7876.45207349876.452073492201730061566309904401
*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.